Expression of BDNF and TrkB Phosphorylation in the Rat Frontal Cortex During Morphine Withdrawal are NO Dependent

Danil I Peregud1,2, Alexander A Yakovlev2, Mikhail Yu Stepanichev2

  • 1Federal State Budgetary Institution "V. Serbsky Federal Medical Research Centre for Psychiatry and Drug Addiction", of the Ministry of Health of the Russian Federation, Moscow, Russia, 119002.

Insights

Nitric oxide (NO) synthesis inhibition during morphine dependence induction worsens withdrawal. This NO modulation impacts brain-derived neurotrophic factor (BDNF) and insulin-like growth factor 1 (IGF1) expression, affecting opioid withdrawal symptoms.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Biology

Background:

  • Nitric oxide (NO) plays a role in opiate effects, including dependence and withdrawal.
  • Neurotrophic factors are implicated in neuronal adaptation during opiate dependence.
  • Mechanisms linking NO modulation to opiate dependence manifestations are not fully understood.

Purpose of the Study:

  • To investigate the effect of inhibiting NO synthesis during morphine dependence induction on neurotrophic factor expression.
  • To examine the impact of NO modulation on brain-derived neurotrophic factor (BDNF), glial-derived neurotrophic factor (GDNF), nerve growth factor (NGF), and insulin-like growth factor 1 (IGF1) expression and their receptors.
  • To assess these changes in specific rat brain regions following spontaneous morphine withdrawal.

Main Methods:

  • Morphine dependence was induced in rats over 6 days using escalating doses of morphine.
  • The nitric oxide synthase inhibitor L-N(G)-nitroarginine methyl ester (L-NAME) was administered before each morphine injection.
  • Expression of BDNF, GDNF, NGF, IGF1, and their receptors was measured in the frontal cortex, striatum, hippocampus, and midbrain post-withdrawal using molecular techniques.

Main Results:

  • L-NAME treatment during morphine intoxication aggravated spontaneous morphine withdrawal severity.
  • Morphine withdrawal upregulated BDNF and IGF1 mRNA in the frontal cortex, and BDNF mRNA in the hippocampus and midbrain.
  • L-NAME administration attenuated these abstinence-induced mRNA increases and reduced the levels of phosphorylated TrkB protein in the frontal cortex.

Conclusions:

  • NO signaling during the induction phase of morphine dependence influences the expression and processing of BDNF.
  • This modulation affects downstream signaling pathways, such as TrkB signaling in the frontal cortex, during opioid withdrawal.
  • NO plays a critical role in the neuroadaptive processes underlying opiate dependence and withdrawal.